PATRIC vs. BV-BRC: Which Platform Should You Use for Bacterial Genome

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• BV-BRC is the successor platform that integrates PATRIC data and tools, so new users should start with BV-BRC for bacterial genome analysis.
• Use PATRIC only if you need access to legacy workflows, historical data, or published analyses that have not yet been migrated to BV-BRC.
• Both platforms are free web-based resources, but BV-BRC offers expanded functionality including additional data types and updated analysis pipelines.

At a Glance

Understanding the Relationship Between PATRIC and BV-BRC

The Pathosystems Resource Integration Center (PATRIC) has served as a primary resource for bacterial genome analysis since its establishment. Researchers have used PATRIC for genome assembly, annotation, and comparative analysis across thousands of bacterial species. The platform provided free access to genomic data and analysis tools that supported studies in microbial pathogenesis, antimicrobial resistance, and infectious disease surveillance.

In 2023, the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) emerged as the integrated successor to PATRIC. BV-BRC combines the functionality of PATRIC with the Viral Bioinformatics Resource Center and the Influenza Research Database. This integration creates a unified platform that supports both bacterial and viral pathogen research within a single interface.

The relationship between these platforms creates practical confusion for researchers. Many published protocols and training materials reference PATRIC, while the active development and new features now appear in BV-BRC. Understanding which platform to use requires consideration of your specific research needs, the age of your existing workflows, and the type of data you plan to analyze.

Core Principles of Bacterial Genome Analysis Platforms

Genome Assembly and Annotation

Bacterial genome analysis begins with raw sequencing reads that require assembly into contiguous sequences. Both PATRIC and BV-BRC provide assembly services that process raw reads from common sequencing platforms. The assembled genomes then undergo annotation, which identifies genes, functional elements, and other genomic features.

The annotation process in both platforms uses a comprehensive approach that combines multiple evidence sources. This includes protein family classification, functional assignment, and metabolic pathway reconstruction. The platforms generate annotations that researchers can use for downstream comparative analyses, including phylogenetic tree construction and pangenome analysis.

Comparative Genomics Tools

Comparative analysis represents a core function of both platforms. Researchers can compare multiple genomes to identify conserved regions, unique genes, and evolutionary relationships. The platforms provide tools for:

• Whole-genome alignment and comparison
• Single nucleotide variant (SNV) analysis
• Pangenome construction and analysis
• Phylogenetic tree building and visualization
• Functional enrichment analysis

These tools enable researchers to address questions about bacterial evolution, pathogenicity, and antimicrobial resistance mechanisms.

Data Storage and Management

Both platforms provide private workspace areas where researchers can store and manage their data. Users can upload their own genomes, organize them into groups, and share them with collaborators. The workspace system allows researchers to maintain control over their data while using the platforms analysis tools.

The data management system also supports the submission of genomes to public databases. Researchers can submit assembled and annotated genomes for public release, contributing to the growing body of publicly available bacterial genomic data.

Practical Workflow for Platform Selection

Step 1: Assess Your Research Needs

Begin by defining the specific requirements of your research project. Consider the type of organism you are studying, the analysis tools you need, and the scale of your data. If you are working exclusively with bacterial genomes, both platforms can support your work. If your research includes viral pathogens or you anticipate expanding to viral analysis, BV-BRC provides the necessary tools.

Step 2: Evaluate Your Existing Data and Workflows

If you have existing data or workflows in PATRIC, you need to determine whether they have been migrated to BV-BRC. The BV-BRC development team has worked to migrate data and tools from PATRIC, but some legacy features may not be fully transferred. Check whether your specific analysis pipelines and saved data are available in BV-BRC before you commit to the transition.

Step 3: Test Both Platforms

Create accounts on both platforms and test your specific analysis workflows. Upload a small test dataset and run your standard analyses. Compare the results, the user interface, and the available documentation. This hands-on testing will help you identify which platform better supports your research needs.

Step 4: Consider Training and Documentation

Review the available training materials, tutorials, and documentation for each platform. BV-BRC provides extensive documentation and training resources that support new users. PATRIC documentation remains available but may not reflect the current state of the platform. Consider the learning curve for your team and the availability of support resources.

Step 5: Plan for the Transition

If you decide to move from PATRIC to BV-BRC, plan the transition carefully. Export your data from PATRIC and import it into BV-BRC. Validate that your analysis workflows produce comparable results. Document any differences in output formats or analysis parameters that may affect your downstream analysis.

Options and Tradeoffs

Using PATRIC for Legacy Workflows

PATRIC remains available for researchers who need to access legacy data or workflows. The platform continues to function, and existing users can continue their work without interruption. However, the platform is no longer the primary focus of development, and new features and data updates will appear in BV-BRC.

The main advantage of staying with PATRIC is continuity. If you have established workflows, saved analyses, and trained team members, you can continue your work without the need to learn a new platform. The main disadvantage is that you will miss out on new features and data updates that appear in BV-BRC.

Using BV-BRC for New Research

BV-BRC represents the current state of the platform and the focus of ongoing development. New data, tools, and features will appear in BV-BRC first. The platform provides a unified interface for bacterial and viral analysis, which may be useful for researchers who work with multiple pathogen types.

The main advantage of BV-BRC is access to the latest tools and data. The main disadvantage is the learning curve associated with the new interface and the potential for differences in analysis results compared to PATRIC.

Hybrid Approach

Some researchers may choose to use both platforms for different purposes. For example, you might use PATRIC to access legacy data and BV-BRC for new analyses. This approach provides flexibility but requires you to maintain familiarity with both platforms.

Observations and Measurements

Data Quality and Validation

The quality of your analysis results depends on the quality of your input data. Both platforms provide quality assessment tools that help you evaluate the completeness and quality of your assembled genomes. These tools generate metrics such as the number of contigs, the N50 value, and the total assembly length.

You should record these quality metrics for each genome you analyze. This documentation helps you track the quality of your data over time and provides context for interpreting your analysis results. The platforms also provide tools for checking the completeness of your assemblies against reference genomes.

Analysis Reproducibility

Reproducibility is a critical consideration in genomic analysis. Both platforms provide version information for their tools and databases, which allows you to document the exact analysis conditions. You should record the platform version, the tool versions, and the database versions used for each analysis.

The platforms also provide the ability to save and share analysis parameters. This feature allows you to reproduce your analysis at a later time or share your analysis parameters with collaborators.

Performance Considerations

The performance of the platforms depends on the size of your dataset and the complexity of your analysis. Large datasets and complex analyses may require significant computational resources. The platforms provide options for adjusting the analysis parameters to balance speed and accuracy.

You should monitor the performance of your analyses and record the time required for each step. This information helps you plan your research timeline and identify potential bottlenecks in your workflow.

Records and Documentation

Data Management Records

Maintain a record of all data you upload to the platforms. This record should include the source of the data, the date of upload, and any relevant metadata. The platforms provide a data management system that tracks your uploaded data, but you should also maintain your own records for backup and reference.

Analysis Records

Document each analysis you perform, including the input data, the analysis parameters, and the output results. This documentation supports the reproducibility of your research and provides a record of your analysis history. The platforms provide a history feature that tracks your analyses, but you should also maintain your own records.

Version Control

Record the version of the platform and the tools used for each analysis. This information is important for reproducing your analysis and for understanding any differences in results between analyses. The platforms provide version information, but you should also record this information in your own documentation.

Common Failure Patterns

Data Upload Failures

Researchers may encounter problems when uploading data to the platform. These problems can result from incorrect file formats, incomplete data, or network issues. The platforms provide error messages that help you identify the cause of the problem. You should verify that your data files are in the correct format and that they contain the required information before uploading.

Analysis Parameter Errors

Incorrect analysis parameters can lead to failed analyses or incorrect results. The platforms provide default parameters that work for most analyses, but you may need to adjust these parameters for your specific data. You should carefully review the analysis parameters before running an analysis and verify that they are appropriate for your data.

Data Interpretation Errors

Misinterpretation of analysis results can lead to incorrect conclusions. The platforms provide visualization tools that help you interpret your results, but you should also have a solid understanding of the biological context of your analysis. You should consult the relevant literature and seek expert advice when interpreting complex analysis results.

Workspace Management Issues

Failure to manage your workspace effectively can lead to data loss or confusion. The platforms provide a workspace management system, but you must use it effectively. You should organize your data into logical groups, use clear naming conventions, and regularly back up your important data.

Quality and Safety Considerations

Data Security

The platforms provide secure storage for your data, but you must also take steps to protect your data. You should use strong passwords, enable two-factor authentication if available, and be careful about sharing your data with others. You should also be aware of the platform data retention policies and ensure that you have backup copies of your important data.

Biosafety Considerations

When working with bacterial genomes, you must consider the biosafety implications of your work. The CDC and NIH Biosafety in Microbiological and Biomedical Laboratories provides guidance on risk assessment, containment, and decontamination for work with biological materials. You should follow these guidelines when handling bacterial strains and when working with genomic data from pathogenic organisms.

Data Privacy and Security

The platforms provide a secure environment for your data, but you must also consider the privacy and security of your data. You should be aware of the platforms data sharing policies and ensure that you have the appropriate permissions to share your data. You should also be aware of the potential for data breaches and take steps to protect your data.

Professional Escalation Criteria

When to Seek Expert Help

You should seek expert help when you encounter problems that you cannot resolve on your own. This includes problems with data quality, analysis results, or platform functionality. The platforms provide support resources, but you may also need to consult with colleagues or experts in your field.

When to Consult a Bioinformatician

You should consult a bioinformatician when you need to perform complex analyses that require specialized expertise. This includes analyses that require custom scripts, advanced statistical methods, or specialized databases. A bioinformatician can help you design and implement your analysis workflow.

When to Seek Institutional Support

You should seek institutional support when you need access to specialized resources or expertise. This includes access to high-performance computing resources, specialized software, or expert consultation. Your institution may have resources available to support your research.

Limitations and Evidence Gaps

Platform Limitations

Both PATRIC and BV-BRC have limitations that you should be aware of. The platforms provide a range of analysis tools, but they may not include every tool you need for your research. You may need to use additional tools or resources to complete your analysis.

Data Limitations

The platforms provide access to a large amount of genomic data, but this data may not be complete or representative. The data may contain errors, and the metadata may be incomplete. You should be aware of these limitations when interpreting your analysis results.

Evidence Gaps

The platforms provide access to a large amount of genomic data, but there are gaps in the data. Some species may be underrepresented, and some regions of the genome may be poorly characterized. You should be aware of these gaps when interpreting your analysis results.

Safety and Regulatory Context

Biosafety Regulations

When working with bacterial genomic data, you must follow the biosafety regulations that apply to your work. The Biosafety in Microbiological and Biomedical Laboratories provides guidance on biosafety practices for work with microorganisms. You must follow these guidelines to ensure the safety of your work.

Data Regulations

The platforms provide a secure environment for your data, but you must also comply with the data regulations that apply to your work. This includes regulations related to data privacy, data security, and data sharing. You should be aware of the regulations that apply to your work and ensure that you comply with them.

Professional Standards

The American Society for Microbiology provides professional standards for microbiology practice. These standards include guidelines for laboratory practice, data management, and professional conduct. You should follow these standards in your work.

Building a Reproducible Analysis Pipeline Across PATRIC and BV-BRC

The Reproducibility Problem in Platform Migration

Researchers who move between PATRIC and BV-BRC face a reproducibility challenge that goes beyond learning a new interface. The two platforms use different database versions, annotation pipelines, and tool implementations. A genome annotated in PATRIC in 2022 may produce different gene calls, functional assignments, or phylogenetic placements when the same raw data is processed through BV-BRC in 2025. These differences are not errors. They reflect the natural evolution of bioinformatics tools and reference databases. However, they create a practical problem for researchers who need to compare results across time, validate published findings, or maintain consistent analysis pipelines for longitudinal surveillance projects.

The solution is not to avoid the transition but to build a reproducibility framework that documents every analysis decision, captures the platform environment, and validates that your results remain interpretable across platform versions. This section provides a concrete framework for building such a pipeline, with specific records you should keep, measurements you should take, and failure patterns you should anticipate.

Why Platform Version Matters for Your Analysis

Both PATRIC and BV-BRC are web-based platforms that run analyses on their own servers. You do not control the software versions, the reference databases, or the underlying computational environment. When you run an assembly, an annotation, or a phylogenetic analysis, the platform uses its current version of each tool. If the platform updates its annotation pipeline, your results may change even if you use the same input data and the same analysis parameters.

This situation is different from running a local bioinformatics tool where you can freeze the software version and reproduce results exactly. With PATRIC and BV-BRC, you must document the platform version and the date of your analysis to understand what environment produced your results. The platforms provide version information in their documentation and in the analysis output files. You should record this information for every analysis you run.

The American Society for Microbiology emphasizes the importance of reproducibility in microbiology research. Their professional standards for laboratory practice include documentation of methods, materials, and data analysis procedures. When you use a web-based platform, your documentation must include the platform version, the database version, and the date of analysis to meet these professional standards.

Building a Platform Transition Record System

Before you move any data from PATRIC to BV-BRC, establish a record system that tracks your analysis history. This system should be a simple spreadsheet or laboratory notebook that you maintain alongside your platform workspace. The record system serves three purposes. It documents your analysis history for reproducibility, it helps you identify which analyses need to be re-run in BV-BRC, and it provides a basis for validating that your results are consistent across platforms.

Your record system should include the following fields for each analysis you run:

You can create this table in a spreadsheet, a laboratory notebook, or a simple text file. The important thing is that you record the information consistently for every analysis. This record system is your primary tool for managing the transition between platforms.

Step-by-Step Pipeline Migration Process

The migration of your analysis pipeline from PATRIC to BV-BRC requires a systematic approach. Do not simply re-run your analyses in the new platform and assume the results are equivalent. Instead, follow a structured process that validates each step of your workflow.

Step 1: Inventory Your Existing Analyses

Begin by listing all the analyses you have performed in PATRIC. This includes assemblies, annotations, comparative analyses, phylogenetic trees, and any other workflows you have used. For each analysis, record the input data, the tool used, the parameters, and the output files. This inventory becomes the basis for your migration plan.

Step 2: Identify Critical Analyses

Not all analyses need to be migrated immediately. Some analyses may be complete and you only need to preserve the results. Other analyses may be part of an ongoing project that requires continued work in BV-BRC. Prioritize the analyses that are critical for your current research and that you will need to extend or reproduce.

Step 3: Export Data from PATRIC

Export your raw data and your analysis results from PATRIC. The platform provides export functions for genomes, annotations, and analysis results. You should export the raw sequencing reads, the assembled contigs, the annotated genomes, and any comparative analysis results. Store these files in a local directory with a clear naming convention that includes the analysis ID and the date.

Step 4: Import Data into BV-BRC

Import your exported data into BV-BRC. The platform provides import functions for genomes and associated metadata. Verify that the import is complete and that the data appears correctly in your BV-BRC workspace. Check the metadata associated with each genome to ensure that it has been transferred correctly.

Step 5: Re-run a Validation Set

Select a small set of representative genomes from your data and re-run your standard analyses in BV-BRC. This validation set should include genomes that represent the range of your data, such as different species, different quality levels, and different analysis types. Compare the results from BV-BRC with the results you obtained from PATRIC.

Step 6: Document Differences

Record any differences between the PATRIC and BV-BRC results. These differences may be in the annotation, the assembly quality metrics, or the phylogenetic tree topology. For each difference, determine whether it is a significant change that affects your interpretation or a minor variation that does not change your conclusions. Document your assessment in your record system.

Step 7: Update Your Pipeline

Based on the validation results, update your analysis pipeline for BV-BRC. This may involve adjusting parameters, using different tools, or changing the way you interpret results. Document the updated pipeline in your record system so that you can reproduce your analyses in the future.

Records and Measurements for Cross-Platform Validation

The validation step is the most important part of the migration process. You need to measure the consistency of your results across platforms and determine whether the differences are acceptable for your research. The following measurements provide a basis for this validation.

Assembly Quality Metrics

For each genome in your validation set, record the assembly quality metrics from both platforms. These metrics include the number of contigs, the N50 value, the total assembly length, and the GC content. Compare the values from PATRIC and BV-BRC. Small differences are expected because the assembly tools may have been updated. Large differences may indicate a problem with the data transfer or a significant change in the assembly algorithm.

Annotation Consistency

Compare the annotations produced by PATRIC and BV-BRC for the same genome. Record the number of genes annotated, the number of proteins with functional assignments, and the number of genes with a specific function. The platforms may use different annotation pipelines, so the numbers may differ. You should determine whether the differences are in the annotation of the same genes or in the identification of different genes.

Phylogenetic Tree Comparison

If you use phylogenetic analysis, compare the trees produced by the two platforms. The tree topology may be the same, but the branch lengths may differ. Record the tree file and the parameters used to generate it. You should also record the method used to compare the trees, such as a tree distance metric.

Antimicrobial Resistance Gene Detection

If your research involves antimicrobial resistance, compare the resistance genes detected by the two platforms. The World Health Organization provides a global context for antimicrobial resistance surveillance and stewardship. The platforms may use different databases for resistance gene detection, so the results may differ. Record the resistance genes detected by each platform and determine whether the differences affect your interpretation.

Common Failure Patterns in Platform Migration

The migration process can fail in several ways. Understanding these failure patterns helps you anticipate problems and respond to them effectively.

Data Transfer Failures

Data transfer failures occur when the export from PATRIC or the import into BV-BRC does not complete correctly. This can result in missing data, corrupted files, or incomplete metadata. You should verify the integrity of your data after each transfer step. Check that the file sizes match, that the metadata is complete, and that the data appears correctly in the new workspace.

Annotation Inconsistencies

Annotation inconsistencies occur when the two platforms produce different annotations for the same genome. This can happen because the platforms use different annotation pipelines or different reference databases. You should compare the annotations and determine whether the differences are in the gene calls, the functional assignments, or the protein features. If the differences are significant, you may need to use a consistent annotation method for your project.

Parameter Mapping Errors

Parameter mapping errors occur when the parameters you used in PATRIC do not have the same meaning in BV-BRC. The platforms may use different names for the same parameter or different default values. You should review the parameter documentation for each platform and verify that your parameters are correctly mapped.

Data Interpretation Errors

Data interpretation errors occur when you interpret the results from BV-BRC using the same assumptions you used for PATRIC. The platforms may produce results in different formats or with different meanings. You should review the output format documentation and verify that you are interpreting the results correctly.

Troubleshooting Method for Cross-Platform Discrepancies

When you encounter a discrepancy between PATRIC and BV-BRC results, use the following troubleshooting method to identify the cause and determine the appropriate response.

Step 1: Verify the Input Data

First, verify that the input data is identical in both platforms. Check the file names, the file sizes, and the file contents. If the input data is different, the results will be different. Re-import the data and re-run the analysis.

Step 2: Check the Platform Versions

Check the platform versions and the database versions used for each analysis. If the versions are different, the results may be different. Record the versions and determine whether the difference is expected.

Step 3: Compare the Parameters

Compare the analysis parameters used in each platform. Check that the parameters are the same or that the differences are intentional. If the parameters are different, re-run the analysis with the same parameters.

Step 4: Examine the Output Format

Examine the output format of the results. The platforms may use different file formats or different data structures. Convert the output to a common format and compare the results.

Step 5: Consult the Documentation

Consult the platform documentation for the specific tool you are using. The documentation may explain the differences in the results or provide guidance on how to interpret them.

Step 6: Seek Expert Help

If you cannot resolve the discrepancy, seek help from a bioinformatician or from the platform support team. Provide them with your record system, your input data, and your analysis parameters. This information helps them identify the cause of the discrepancy.

The Role of Reference Materials in Validation

The American Type Culture Collection provides authenticated biological materials that are useful for validating your analysis pipeline. ATCC strains have known genomic sequences and well-characterized phenotypes. You can use these strains to validate that your pipeline produces the expected results. For example, you can sequence an ATCC strain, assemble the genome, and compare the assembly to the reference genome. This comparison helps you determine whether your pipeline is working correctly.

The U.S. Food and Drug Administration provides the Bacteriological Analytical Manual, which includes official methods for food microbiology. These methods provide a context for the quality and validation of your analysis. The manual includes methods for the detection and identification of foodborne pathogens, which may be relevant to your research.

Professional Escalation Criteria for Platform Migration

You should escalate the migration process to a bioinformatician or an institutional expert when you encounter problems that you cannot resolve with the troubleshooting method. The following criteria indicate that you should seek expert help.

When the Discrepancy Affects Your Conclusions

If the differences between PATRIC and BV-BRC results affect your research conclusions, you should seek expert help. A bioinformatician can help you determine whether the differences are due to the platform, the data, or your interpretation.

When You Cannot Identify the Cause

If you cannot identify the cause of a discrepancy after following the troubleshooting method, you should seek expert help. The problem may be in the platform, in your data, or in your analysis parameters.

When You Need to Validate a Large Dataset

If you are migrating a large dataset, you may need to validate the migration with a statistical approach. A bioinformatician can help you design a validation strategy that is appropriate for the size and complexity of your data.

When You Need to Meet Regulatory Requirements

If your research is subject to regulatory requirements, you may need to validate your platform and your analysis to meet those requirements. The Clinical and Laboratory Standards Institute provides standards for antimicrobial susceptibility testing that may be relevant to your research. You should consult with your institutional compliance office to determine the requirements that apply to your work.

Biosafety and Data Management in the Migration Process

The migration process involves handling genomic data from potentially pathogenic organisms. You must follow the biosafety guidelines provided by the CDC and NIH Biosafety in Microbiological and Biomedical Laboratories. These guidelines provide a framework for risk assessment, containment, and decontamination. When you export data from PATRIC and import it into BV-BRC, you should ensure that your data is handled securely and that you comply with your institutional data management policies.

The American Society for Microbiology provides professional standards for microbiology practice. These standards include guidelines for data management and professional conduct. You should follow these standards when you migrate your data and when you document your analysis.

Building a Long-Term Reproducibility Strategy

The migration from PATRIC to BV-BRC is not a one-time event. The platforms will continue to evolve, and you will need to update your analysis pipeline as new versions are released. A long-term reproducibility strategy includes the following elements.

Version Control for Your Analysis

You should maintain a version control system for your analysis pipeline. This system should track the versions of your data, your parameters, and your analysis scripts. You can use a simple spreadsheet or a version control system such as Git.

Regular Validation

You should regularly validate your analysis pipeline by re-running a validation set and comparing the results. This validation helps you detect changes in the platform that may affect your results.

Documentation of Your Analysis

You should document your analysis in a way that is reproducible. This includes recording the platform version, the database version, the tool version, the parameters, and the date of your analysis.

Training and Professional Development

You should stay current with the platform documentation and the professional standards for microbiology. The American Society for Microbiology provides training and professional development resources that help you maintain your skills.

The Role of the Platform in Your Research Workflow

The platform you choose is a tool in your research workflow. The platform does not replace your expertise or your judgment. You must interpret the results, validate the findings, and communicate the conclusions. The platform provides the computational infrastructure, but you provide the scientific context.

The World Health Organization provides a global context for antimicrobial resistance research. Your analysis of bacterial genomes contributes to the global effort to understand and combat antimicrobial resistance. The platform you use is a means to that end.

The U.S. Food and Drug Administration provides official methods for food microbiology. These methods provide a context for the quality and validation of your analysis. The platform you use should support the quality and validation of your work.

A Decision Framework for Platform Use

The following decision framework helps you determine when to use PATRIC and when to use BV-BRC for your analysis.

Use BV-BRC for New Analyses

For any new analysis, use BV-BRC. The platform is the current focus of development, and it provides the latest tools and data. BV-BRC is the appropriate platform for new research projects, for new data, and for new analyses.

Use PATRIC for Legacy Data

Use PATRIC to access legacy data that has not been migrated to BV-BRC. If you have saved analyses in PATRIC that you need to access, you can use PATRIC to retrieve them. You should export the data and import it into BV-BRC for your ongoing work.

Use Both Platforms for Validation

Use both platforms for validation. When you migrate your data, you can use PATRIC to validate the results from BV-BRC. This validation helps you ensure that your results are consistent across platforms.

Use BV-BRC for Collaborative Work

Use BV-BRC for collaborative work. The platform provides a shared workspace that supports collaboration. You can share your data and your analyses with your collaborators.

The Role of the Platform in Your Professional Practice

The platform is a professional tool that supports your research. Your professional practice includes the use of the platform, the documentation of your analysis, and the interpretation of your results. The American Society for Microbiology provides professional standards for microbiology practice. These standards include the use of appropriate tools, the documentation of your methods, and the interpretation of your results.

The Clinical and Laboratory Standards Institute provides standards for antimicrobial susceptibility testing. These standards provide a context for the interpretation of your analysis. You should follow these standards when you interpret your results.

The Future of Your Analysis Pipeline

The platform will continue to evolve. You should plan for the evolution of your analysis pipeline. This includes the regular validation of your pipeline, the documentation of your analysis, and the training of your team. The platform is a tool that supports your research, and your research is the focus of your work.

The World Health Organization provides a global context for antimicrobial resistance research. Your analysis of the platform contributes to the global effort to understand and combat antimicrobial resistance. The platform is a means to that end, and your research is the goal.

Frequently Asked Questions

What is the main difference between PATRIC and BV-BRC?

BV-BRC is the integrated platform that combines PATRIC with viral bioinformatics resources. It provides a unified interface for bacterial and viral analysis, while PATRIC is the legacy platform focused on bacterial genomes.

Should I use PATRIC or BV-BRC for my bacterial genome analysis?

For new analyses, you should use BV-BRC because it is the current platform with ongoing development and data updates. Use PATRIC only if you need to access legacy data or workflows that have not been migrated.

Can I transfer my data from PATRIC to BV-BRC?

Yes, you can export your data from PATRIC and import it into BV-BRC. You should test your imported data to ensure that it is complete and that your analysis workflows produce comparable results.

Will PATRIC continue to be available?

PATRIC remains available for existing users, but it is no longer the primary focus of development. New features and data updates will primarily appear in BV-BRC.

What types of analysis can I perform with BV-BRC?

BV-BRC provides tools for genome assembly, annotation, comparative analysis, phylogenetic analysis, and pangenome analysis. It also provides tools for viral genome analysis.

How do I ensure the quality of my analysis results?

You should use the quality assessment tools provided by the platform, record the quality metrics for your data, and document the analysis parameters and versions used for each analysis.

What should I do if I encounter problems with the platform?

You should consult the platform documentation and support resources. If you cannot resolve the problem, you should seek help from a bioinformatician or contact the platform support team.

How do I ensure the biosafety of my work with bacterial genomic data?

Follow the biosafety guidelines provided by the CDC and NIH and the professional standards from the American Society for Microbiology. Ensure that your laboratory follows the appropriate biosafety practices for your work.

Related Bacteriology Guides

• Bacterial Contamination of Poultry: Salmonella and E. coli
• Bacterial Diseases of Chickens: A Comprehensive Overview
• Bacterial Growth Dynamics in Chicken: From Farm to Refrigeration
• Bacterial Pathogens in Poultry: Comprehensive Clinical Reference
• Bacterial Poultry Diseases: Comprehensive Overview and Classification

References and Further Reading

• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• Microbiology Resources. American Society for Microbiology.
• Antimicrobial Resistance. World Health Organization.
• Bacteriological Analytical Manual. U.S. Food and Drug Administration.
• Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
• Culture Collections. American Type Culture Collection.
• NCBI Pathogen Detection. National Center for Biotechnology Information.
• First comprehensive whole genome sequencing report of a multidrug-resistant &lt,i&gt,Serratia nematodiphila&lt,/i&gt, strain from Bangladesh.. 2026.
• Comparative genomic characterization of <i>Cellulosimicrobium funkei</i> isolate RVMD1 from Ma'an desert rock varnish challenges <i>Cellulosimicrobium</i> systematics.. 2024.
• Comprehensive genome analysis of &lt,i&gt,Mycobacterium avium&lt,/i&gt, subsp. &lt,i&gt,paratuberculosis&lt,/i&gt, in camels from Saudi Arabia: Molecular epidemiology and antimicrobial resistance.. 2025.
• Genomic characterization of Salmonella enterica isolates causing typhoid among Ghanaian patients.. 2026.

This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.